Minyoung Kim brings global insight to healthcare and technology organizations, having served multinational and local companies in Korea, Japan, and the United States. He assists clients in developing and executing strategies as well as improving processes critical to business growth such as R&D, innovation, and new business-development and product launches. Although his primary focus is serving organizations in the healthcare and technology sectors, he also has experience serving energy, financial services, and travel/logistics companies.
Healthcare companies around the world are searching for new business opportunities. Minyoung supports clients in their efforts to identify and develop promising alliances, conduct new business feasibility assessments, analyze consumer/customer insights to inform product and service development, and evaluate and refine new market entry and product-launch strategies.
Minyoung’s recent contributions in the healthcare industry include helping a Korean firm refine its global regulatory strategy and serving a Japanese company by refining a branding strategy for its branded-drug portfolio. His experience as an MD is invaluable in the area of pharmaceuticals, and he has helped many companies improve their R&D and product-innovation processes such as candidate scanning, investment prioritization, pipeline-strength assessment, and clinical development strategies.
Minyoung also applies his R&D and innovation experience in the technology industry, especially in areas where technology meets healthcare. He recently oversaw a large-scale innovation program for a Korean technology player.
Minyoung is a frequent contributor to McKinsey’s internal knowledge development efforts related to the healthcare sector. Before receiving his MBA from Harvard Business School Minyoung was a clinical fellow of transplantation surgery at Seoul National University Hospital where he also completed his surgical residency.
|Harvard Business School
|Seoul National University
||MD and MSc